Athenex to ex­it drug com­pound­ing busi­ness and axe 92 em­ploy­ees at NY plant

The New York-based can­cer biotech Athenex has faced some strug­gles over the past year, but the com­pa­ny is mov­ing to shut­ter the doors of one of its man­u­fac­tur­ing sites.

Ac­cord­ing to a WARN no­tice post­ed by the New York State De­part­ment of La­bor, Athenex will be ax­ing around 92 em­ploy­ees at its plant in the town of Clarence, New York, just to the east of its HQ in Buf­fa­lo. The no­tice said that the move will be done by March 17.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER